236 related articles for article (PubMed ID: 31919619)
1. Drug repurposing towards targeting cancer stem cells in pediatric brain tumors.
Bahmad HF; Elajami MK; El Zarif T; Bou-Gharios J; Abou-Antoun T; Abou-Kheir W
Cancer Metastasis Rev; 2020 Mar; 39(1):127-148. PubMed ID: 31919619
[TBL] [Abstract][Full Text] [Related]
2. Repurposing of Anticancer Stem Cell Drugs in Brain Tumors.
Bahmad HF; Daher D; Aljamal AA; Elajami MK; Oh KS; Alvarez Moreno JC; Delgado R; Suarez R; Zaldivar A; Azimi R; Castellano A; Sackstein R; Poppiti RJ
J Histochem Cytochem; 2021 Dec; 69(12):749-773. PubMed ID: 34165342
[TBL] [Abstract][Full Text] [Related]
3. Promoting oligodendroglial-oriented differentiation of glioma stem cell: a repurposing of quetiapine for the treatment of malignant glioma.
Wang Y; Huang N; Li H; Liu S; Chen X; Yu S; Wu N; Bian XW; Shen HY; Li C; Xiao L
Oncotarget; 2017 Jun; 8(23):37511-37524. PubMed ID: 28415586
[TBL] [Abstract][Full Text] [Related]
4. Concise review: bullseye: targeting cancer stem cells to improve the treatment of gliomas by repurposing disulfiram.
Triscott J; Rose Pambid M; Dunn SE
Stem Cells; 2015 Apr; 33(4):1042-6. PubMed ID: 25588723
[TBL] [Abstract][Full Text] [Related]
5. Clinical relevance of tumor cells with stem-like properties in pediatric brain tumors.
Thirant C; Bessette B; Varlet P; Puget S; Cadusseau J; Tavares Sdos R; Studler JM; Silvestre DC; Susini A; Villa C; Miquel C; Bogeas A; Surena AL; Dias-Morais A; Léonard N; Pflumio F; Bièche I; Boussin FD; Sainte-Rose C; Grill J; Daumas-Duport C; Chneiweiss H; Junier MP
PLoS One; 2011 Jan; 6(1):e16375. PubMed ID: 21297991
[TBL] [Abstract][Full Text] [Related]
6. Cancer stem cells and the biology of brain tumors.
Flores DG; Ledur PF; Abujamra AL; Brunetto AL; Schwartsmann G; Lenz G; Roesler R
Curr Stem Cell Res Ther; 2009 Dec; 4(4):306-13. PubMed ID: 19804368
[TBL] [Abstract][Full Text] [Related]
7. Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumors.
Folkins C; Man S; Xu P; Shaked Y; Hicklin DJ; Kerbel RS
Cancer Res; 2007 Apr; 67(8):3560-4. PubMed ID: 17440065
[TBL] [Abstract][Full Text] [Related]
8. New advances of microRNAs in glioma stem cells, with special emphasis on aberrant methylation of microRNAs.
Zhao B; Bian EB; Li J; Li J
J Cell Physiol; 2014 Sep; 229(9):1141-7. PubMed ID: 24374932
[TBL] [Abstract][Full Text] [Related]
9. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells.
Jhaveri N; Agasse F; Armstrong D; Peng L; Commins D; Wang W; Rosenstein-Sisson R; Vaikari VP; Santiago SV; Santos T; Chen L; Schönthal AH; Chen TC; Hofman FM
Cancer Lett; 2016 Feb; 371(2):240-50. PubMed ID: 26683773
[TBL] [Abstract][Full Text] [Related]
10. Targeting glioma stem cells: a novel framework for brain tumors.
Binello E; Germano IM
Cancer Sci; 2011 Nov; 102(11):1958-66. PubMed ID: 21848914
[TBL] [Abstract][Full Text] [Related]
11. Repurposing phenformin for the targeting of glioma stem cells and the treatment of glioblastoma.
Jiang W; Finniss S; Cazacu S; Xiang C; Brodie Z; Mikkelsen T; Poisson L; Shackelford DB; Brodie C
Oncotarget; 2016 Aug; 7(35):56456-56470. PubMed ID: 27486821
[TBL] [Abstract][Full Text] [Related]
12. Drug Repurposing of Metabolic Agents in Malignant Glioma.
Seliger C; Hau P
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30223473
[TBL] [Abstract][Full Text] [Related]
13. Hitting a Moving Target: Glioma Stem Cells Demand New Approaches in Glioblastoma Therapy.
Spencer DA; Auffinger BM; Murphy JP; Muroski ME; Qiao J; Gorind Y; Lesniak MS
Curr Cancer Drug Targets; 2017; 17(3):236-254. PubMed ID: 27993114
[TBL] [Abstract][Full Text] [Related]
14. A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells.
Kim RK; Kim MJ; Yoon CH; Lim EJ; Yoo KC; Lee GH; Kim YH; Kim H; Jin YB; Lee YJ; Cho CG; Oh YS; Gye MC; Suh Y; Lee SJ
Mol Pharmacol; 2012 Sep; 82(3):400-7. PubMed ID: 22648970
[TBL] [Abstract][Full Text] [Related]
15. Effective treatment of glioblastoma requires crossing the blood-brain barrier and targeting tumors including cancer stem cells: The promise of nanomedicine.
Kim SS; Harford JB; Pirollo KF; Chang EH
Biochem Biophys Res Commun; 2015 Dec; 468(3):485-9. PubMed ID: 26116770
[TBL] [Abstract][Full Text] [Related]
16. Differentiation therapy exerts antitumor effects on stem-like glioma cells.
Campos B; Wan F; Farhadi M; Ernst A; Zeppernick F; Tagscherer KE; Ahmadi R; Lohr J; Dictus C; Gdynia G; Combs SE; Goidts V; Helmke BM; Eckstein V; Roth W; Beckhove P; Lichter P; Unterberg A; Radlwimmer B; Herold-Mende C
Clin Cancer Res; 2010 May; 16(10):2715-28. PubMed ID: 20442299
[TBL] [Abstract][Full Text] [Related]
17. [Chemotherapeutic treatment of gliomas increases the amount of cancer stem-like cells].
Bleau AM; Holland EC
Med Sci (Paris); 2009 Oct; 25(10):775-7. PubMed ID: 19849969
[No Abstract] [Full Text] [Related]
18. Tumorigenesis of chemotherapeutic drug-resistant cancer stem-like cells in brain glioma.
Kang MK; Kang SK
Stem Cells Dev; 2007 Oct; 16(5):837-47. PubMed ID: 17999604
[TBL] [Abstract][Full Text] [Related]
19. Glioma stem cells: markers, hallmarks and therapeutic targeting by metformin.
Najbauer J; Kraljik N; Németh P
Pathol Oncol Res; 2014 Oct; 20(4):789-97. PubMed ID: 25168767
[TBL] [Abstract][Full Text] [Related]
20. Migrating glioma cells express stem cell markers and give rise to new tumors upon xenografting.
Munthe S; Sørensen MD; Thomassen M; Burton M; Kruse TA; Lathia JD; Poulsen FR; Kristensen BW
J Neurooncol; 2016 Oct; 130(1):53-62. PubMed ID: 27510953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
